Haemonetics 3rd Quarter Fiscal Year 2021 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
Haemonetics (HAE) Tops Q3 EPS by 15c, Revenues Beat
February 2, 2021 6:09 AM ESTHaemonetics (NYSE: HAE) reported Q3 EPS of $0.81, $0.15 better than the analyst estimate of $0.66. Revenue for the quarter came in at $240 million versus the consensus estimate of $225.73 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
... More


